Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Alan Chalil, Michael D. Staudt, Tessa A. Harland, Elizabeth M. Leimer, Ravneet Bhullar & Charles E. Argoff. (2021) A safety review of approved intrathecal analgesics for chronic pain management. Expert Opinion on Drug Safety 20:4, pages 439-451.
Read now
Read now
Timothy Deer & Jonathan M. Hagedorn. (2020) How has ziconotide impacted non-cancer pain management?. Expert Opinion on Pharmacotherapy 21:5, pages 507-511.
Read now
Read now
Brandon P Staub, Gianna P Casini, Edward A Monaco$suffix/text()$suffix/text(), Raymond F Sekula$suffix/text()$suffix/text() & Trent D Emerick. (2019) Near-resolution of persistent idiopathic facial pain with low-dose lumbar intrathecal ziconotide: a case report. Journal of Pain Research 12, pages 945-949.
Read now
Read now
Michael Saulino, Philip S Kim & Erik Shaw. (2014) Practical considerations and patient selection for intrathecal drug delivery in the management of chronic pain. Journal of Pain Research 7, pages 627-638.
Read now
Read now
Jason E Pope & Timothy R Deer. (2013)
Ziconotide: a clinical update and pharmacologic review. Expert Opinion on Pharmacotherapy 14:7, pages 957-966.
Read now
Read now
Nikolai G Rainov & Volkmar Heidecke. (2011) Targeted biological therapies for pain. Expert Opinion on Biological Therapy 11:10, pages 1315-1326.
Read now
Read now
Avinash K Bhandary, Gary P Chimes & Gerard A Malanga. (2010) Investigational pharmacology for low back pain. Journal of Pain Research 3, pages 169-181.
Read now
Read now
Articles from other publishers (61)
Salim M Hayek, Bradford A Jones, Elias Veizi, Thang Q Tran & Sarah J DeLozier. (2023) Efficacy of Continuous Intrathecal Infusion Trialing with a Mixture of Fentanyl and Bupivacaine in Chronic Low Back Pain Patients. Pain Medicine 24:7, pages 796-808.
Crossref
Crossref
Xiufang Ding, Yue Wang, Sida Zhang, Ruihua Zhang, Dong Chen, Long Chen, Yu Zhang, Shi-Zhong Luo, Jianfu Xu & Chengxin Pei. (2023) Self-Assembly Nanostructure of Myristoylated ω-Conotoxin MVIIA Increases the Duration of Efficacy and Reduces Side Effects. Marine Drugs 21:4, pages 229.
Crossref
Crossref
Neshatul Haque, Sana Parveen, Tingting Tang, Jiaen Wei & Zunnan Huang. (2022) Marine Natural Products in Clinical Use. Marine Drugs 20:8, pages 528.
Crossref
Crossref
Julien Robert, Jérémy Sorrieul, Denis Dupoiron, Sabrina Jubier-Hamon, Florent Bienfait, Anne Visbecq & Catherine Devys. (2022) Physicochemical Stability Study of the Morphine-Ropivacaine-Ziconotide Association in Implantable Pumps for Intrathecal Administration. Neuromodulation: Technology at the Neural Interface.
Crossref
Crossref
Amanda Su, Hannah Johnson, Colleen Taylor & Sarah Oros. (2021) Ziconotide-induced psychosis in patient without previous psychiatric history: A case report. Personalized Medicine in Psychiatry 29-30, pages 100086.
Crossref
Crossref
Zhiping Jia, Yunyang Liu, Xiaoru Ji, Yizheng Zheng, Zhengyang Li, Shuai Jiang, Hongjin Li & Yi Kong. (2021) DAKS1, a Kunitz Scaffold Peptide from the Venom Gland of Deinagkistrodon acutus Prevents Carotid-Artery and Middle-Cerebral-Artery Thrombosis via Targeting Factor XIa. Pharmaceuticals 14:10, pages 966.
Crossref
Crossref
Elsie C. Jimenez. (2021) Post-translationally modified conopeptides: Biological activities and pharmacological applications. Peptides 139, pages 170525.
Crossref
Crossref
Georgios Matis, Pasquale De Negri, Denis Dupoiron, Rudolf Likar, Xander Zuidema & Dirk Rasche. (2021) Intrathecal pain management with ziconotide: Time for consensus?. Brain and Behavior 11:S1.
Crossref
Crossref
Miriam M. Shao, Olga Khazen, Abigail Hellman, Margaret Czerwinski, Rachel Dentinger, Marisa DiMarzio, Michael Gillogly, Amir Hadanny, Charles Argoff & Julie G. Pilitsis. (2021) Effect of First-Line Ziconotide Intrathecal Drug Therapy for Neuropathic Pain on Disability, Emotional Well-Being, and Pain Catastrophizing. World Neurosurgery 145, pages e340-e347.
Crossref
Crossref
Michael Suer & Nalini SehgalMichael Suer & Nalini Sehgal. 2021. Questions and Answers in Pain Medicine. Questions and Answers in Pain Medicine
197
208
.
Ratan K Banik & Mitchell P Engle. (2020) Ziconotide for Management of Cancer Pain Refractory to Pharmacotherapy: An Update. Pain Medicine 21:12, pages 3253-3259.
Crossref
Crossref
Karla de Castro Figueiredo Bordon, Camila Takeno Cologna, Elisa Corrêa Fornari-Baldo, Ernesto Lopes Pinheiro-Júnior, Felipe Augusto Cerni, Fernanda Gobbi Amorim, Fernando Antonio Pino Anjolette, Francielle Almeida Cordeiro, Gisele Adriano Wiezel, Iara Aimê Cardoso, Isabela Gobbo Ferreira, Isadora Sousa de Oliveira, Johara Boldrini-França, Manuela Berto Pucca, Mateus Amaral Baldo & Eliane Candiani Arantes. (2020) From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery. Frontiers in Pharmacology 11.
Crossref
Crossref
Claudio Antonio da Silva Junior, Célio José de Castro Junior, Elizete Maria Rita Pereira, Nancy Scardua Binda, Juliana Figueira da Silva, Marta do Nascimento Cordeiro, Danuza Montijo Diniz, Flavia Santa Cecilia, Juliano Ferreira & Marcus Vinicius Gomez. (2020) The inhibitory effect of Phα1β toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor. Pharmacological Reports 72:1, pages 47-54.
Crossref
Crossref
Xinwang Yang, Ying Wang, Chunyun Wu & Eng-Ang Ling. (2019) Animal Venom Peptides as a Treasure Trove for New Therapeutics Against Neurodegenerative Disorders. Current Medicinal Chemistry 26:25, pages 4749-4774.
Crossref
Crossref
Alessandra Hubner de Souza, Luiza Gabriela da Rosa, Michel Rossi Uliano, Lismare da Silva Prado, Alice Gomes Ferraz, Lucas Umpierre Conter, Ivana Grivicich, Eliane Dallegrave, Marcus Vinícius Gomez & Jaqueline Nascimento Picada. (2018)
Evaluation of DNA damage in spinal cord and mutagenic effect of a Phα1β recombinant toxin with analgesic properties from the
Phoneutria nigriventer
spider
. Basic & Clinical Pharmacology & Toxicology 124:5, pages 615-620.
Crossref
Crossref
Vishad V. Sukul. (2019) Intrathecal Pain Therapy for the Management of Chronic Noncancer Pain. Neurosurgery Clinics of North America 30:2, pages 195-201.
Crossref
Crossref
Lucas W. Campos. 2019. Deer's Treatment of Pain. Deer's Treatment of Pain
655
660
.
Doreen Könning & Harald Kolmar. (2018) Beyond antibody engineering: directed evolution of alternative binding scaffolds and enzymes using yeast surface display. Microbial Cell Factories 17:1.
Crossref
Crossref
E. Bäckryd. (2018) Do the potential benefits outweigh the risks? An update on the use of ziconotide in clinical practice. European Journal of Pain 22:7, pages 1193-1202.
Crossref
Crossref
Chen-Chen Chen, Shuai Gao, Hua-Song Ai, Qian Qu, Chang-Lin Tian & Yi-Ming Li. (2018) Racemic X-ray structure of L-type calcium channel antagonist Calciseptine prepared by total chemical synthesis. Science China Chemistry 61:6, pages 702-707.
Crossref
Crossref
Stéphane La Barre & Stephen S. BatesStephan Böttcher, Angela Di Capua, John W. Blunt & Ronald J. Quinn. 2018. Blue Biotechnology. Blue Biotechnology
297
321
.
Jessica M. de Souza, Bruno D. C. Goncalves, Marcus V. Gomez, Luciene B. Vieira & Fabiola M. Ribeiro. (2018) Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases. Frontiers in Pharmacology 9.
Crossref
Crossref
Rudo Simeon & Zhilei Chen. (2017) In vitro-engineered non-antibody protein therapeutics. Protein & Cell 9:1, pages 3-14.
Crossref
Crossref
Gemayel Lee & Jeffrey Chen. 2018. Challenging Cases and Complication Management in Pain Medicine. Challenging Cases and Complication Management in Pain Medicine
225
231
.
Paolo Maino, Roberto S.G.M. Perez & Eva Koetsier. (2017) Intrathecal Pump Refills, Pocket Fills, and Symptoms of Drug Overdose: A Prospective, Observational Study Comparing the Injected Drug Volume vs. the Drug Volume Effectively Measured Inside the Pump. Neuromodulation: Technology at the Neural Interface 20:7, pages 733-739.
Crossref
Crossref
Leticia Coelho-Silva, Gary J. StephensHelena Cimarosti. (2017) SUMOylation and calcium signalling: potential roles in the brain and beyond. Neuronal Signaling 1:3.
Crossref
Crossref
Julia Prusik, Charles Argoff, Sophia Peng & Julie G. Pilitsis. (2017) Use of Low Dose Ziconotide as First-Line Intrathecal Monotherapy. Neuromodulation: Technology at the Neural Interface 20:4, pages 386-391.
Crossref
Crossref
Chawita Netirojjanakul & Les P Miranda. (2017) Progress and challenges in the optimization of toxin peptides for development as pain therapeutics. Current Opinion in Chemical Biology 38, pages 70-79.
Crossref
Crossref
Sephalie Patel, Osama Hafez, Wade J. Sexton & David A. Edwards. (2017) Perioperative Management of a Patient With an Intrathecal Drug Delivery Device Infusing Ziconotide. A & A Case Reports 8:4, pages 78-80.
Crossref
Crossref
G.G. Gurkoff, K. Shahlaie, B.G. Lyeth & R.F. Berman. 2017. New Therapeutics for Traumatic Brain Injury. New Therapeutics for Traumatic Brain Injury
179
197
.
Jason E. PopeTimothy R. DeerBrian M. BruelSteven Falowski. (2016) Clinical Uses of Intrathecal Therapy and Its Placement in the Pain Care Algorithm. Pain Practice 16:8, pages 1092-1106.
Crossref
Crossref
Gladstone C. McDowell II & Jason E. Pope. (2016) Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain. Neuromodulation: Technology at the Neural Interface 19:5, pages 522-532.
Crossref
Crossref
Sara M. Oliveira, Cássia R. Silva, Gabriela Trevisan, Jardel G. Villarinho, Marta N. Cordeiro, Michael Richardson, Márcia H. Borges, Célio J. CastroJr.Jr., Marcus V. Gomez & Juliano Ferreira. (2016) Antinociceptive effect of a novel armed spider peptide Tx3-5 in pathological pain models in mice. Pflügers Archiv - European Journal of Physiology 468:5, pages 881-894.
Crossref
Crossref
Gerald W. Zamponi. (2015) Targeting voltage-gated calcium channels in neurological and psychiatric diseases. Nature Reviews Drug Discovery 15:1, pages 19-34.
Crossref
Crossref
Kasra Amirdelfan. 2016. Integrating Pain Treatment into Your Spine Practice. Integrating Pain Treatment into Your Spine Practice
131
147
.
Lynn R. Webster. (2015) The Relationship Between the Mechanisms of Action and Safety Profiles of Intrathecal Morphine and Ziconotide: A Review of the Literature. Pain Medicine 16:7, pages 1265-1277.
Crossref
Crossref
Emmanuel Bäckryd, Jan Sörensen & Björn Gerdle. (2015) Ziconotide Trialing by Intrathecal Bolus Injections: An Open-Label Non-Randomized Clinical Trial in Postoperative/Posttraumatic Neuropathic Pain Patients Refractory to Conventional Treatment. Neuromodulation: Technology at the Neural Interface 18:5, pages 404-413.
Crossref
Crossref
Christian Horazeck, Albert S. Huh & Billy K. Huh. (2015) Acute Rhabdomyolysis in a Patient with Long-Term Exposure to Intrathecal Ziconotide: A Case Report. Pain Practice 15:3, pages E34-E39.
Crossref
Crossref
Fernanda Rosa, Gabriela Trevisan, Flávia Karine Rigo, Raquel Tonello, Edinéia Lemos Andrade, Marta do Nascimento Cordeiro, João Batista Calixto, Marcus Vinícius Gomez & Juliano Ferreira. (2014) Phα1β, a Peptide from the Venom of the Spider Phoneutria Nigriventer Shows Antinociceptive Effects after Continuous Infusion in a Neuropathic Pain Model in Rats. Anesthesia & Analgesia 119:1, pages 196-202.
Crossref
Crossref
Kalyana B. Akondi, Markus Muttenthaler, Sébastien Dutertre, Quentin Kaas, David J. Craik, Richard J. Lewis & Paul F. Alewood. (2014) Discovery, Synthesis, and Structure–Activity Relationships of Conotoxins. Chemical Reviews 114:11, pages 5815-5847.
Crossref
Crossref
Joshua Prager, Timothy Deer, Robert Levy, Brian Bruel, Eric Buchser, David Caraway, Michael Cousins, Marilyn Jacobs, Gail McGlothlen, Richard Rauck, Peter Staats & Lisa Stearns. (2014) Best Practices for Intrathecal Drug Delivery for Pain. Neuromodulation: Technology at the Neural Interface 17:4, pages 354-372.
Crossref
Crossref
Robert W. Hurley, Dustin Anderson & Steven P. Cohen. 2014. Practical Management of Pain. Practical Management of Pain
582
595.e5
.
Lubica Lacinová & Lucia Lichvárová. 2014. Pathologies of Calcium Channels. Pathologies of Calcium Channels
297
314
.
Salma I. Mohammed, Sam Eldabe, Karen H. Simpson, Morag Brookes, Grace Madzinga, Ashish Gulve, Ganesan Baranidharan, Helen Radford, Tracey Crowther, Eric Buchser, Christophe Perruchoud & Alan Mark Batterham. (2013) Bolus Intrathecal Injection of Ziconotide (Prialt®) to Evaluate the Option of Continuous Administration via an Implanted Intrathecal Drug Delivery (ITDD) System: A Pilot Study. Neuromodulation: Technology at the Neural Interface 16:6, pages 576-582.
Crossref
Crossref
Gene Gurkoff, Kiarash Shahlaie, Bruce Lyeth & Robert Berman. (2013) Voltage-Gated Calcium Channel Antagonists and Traumatic Brain Injury. Pharmaceuticals 6:7, pages 788-812.
Crossref
Crossref
George Miljanich, Richard Rauck & Michael Saulino. (2013) Spinal Mechanisms of Pain and Analgesia. Pain Practice 13:2, pages 114-130.
Crossref
Crossref
Marie Fallon. 2013. Cancer Pain. Cancer Pain
153
164
.
Tony L. Yaksh, Annelies de Kater, Robin Dean, Brookie M. Best & George P. Miljanich. (2012) Pharmacokinetic Analysis of Ziconotide (SNX-111), an Intrathecal N-Type Calcium Channel Blocking Analgesic, Delivered by Bolus and Infusion in the Dog. Neuromodulation: Technology at the Neural Interface 15:6, pages 508-519.
Crossref
Crossref
Rowan Dobson, Mike Collodoro, Nicolas Gilles, Andrei Turtoi, Edwin De Pauw & Loïc Quinton. (2012) Secretion and maturation of conotoxins in the venom ducts of Conus textile. Toxicon 60:8, pages 1370-1379.
Crossref
Crossref
Howard S. Smith & Marco Pappagallo. 2012. Essential Pain Pharmacology. Essential Pain Pharmacology
489
492
.
Ilaria Alicino, Mariateresa Giglio, Fabio Manca, Francesco Bruno & Filomena Puntillo. (2012) Intrathecal combination of ziconotide and morphine for refractory cancer pain: A rapidly acting and effective choice. Pain 153:1, pages 245-249.
Crossref
Crossref
G. Calvo-Mosquera, A. Gonzalez-Cal, G.A. Martinez-Nieto, L. Pita-Pardo, D. Calvo-Rodriguez, C.J. Primucci & B.P. Duarte-Bermúdez. (2012) Un “veneno” para el dolor. El ziconotide. Farmacéuticos de Atención Primaria 10:3, pages 63-67.
Crossref
Crossref
Shannon L. Bianchi & Michael A. Ashburn. 2012. Intrathecal Drug Delivery for Pain and Spasticity�. Intrathecal Drug Delivery for Pain and Spasticity�
30
36
.
A.H. de Souza, M.C. Lima, C.C. Drewes, J.F. da Silva, K.C.L. Torres, E.M.R. Pereira, C.J. de CastroJuniorJunior, L.B. Vieira, M.N. Cordeiro, M. Richardson, R.S. Gomez, M.A. Romano-Silva, J. Ferreira & M.V. Gomez. (2011) Antiallodynic effect and side effects of Phα1β, a neurotoxin from the spider Phoneutria nigriventer: Comparison with ω-conotoxin MVIIA and morphine. Toxicon 58:8, pages 626-633.
Crossref
Crossref
Youssef Rezk, Patrick F. TimminsHoward S. Smith. (2010) Review Article: Palliative Care in Gynecologic Oncology. American Journal of Hospice and Palliative Medicine® 28:5, pages 356-374.
Crossref
Crossref
Marlene L. Johnson, Eric J. Visser & C. Roger Goucke. (2011) Massive Clonidine Overdose During Refill of an Implanted Drug Delivery Device for Intrathecal Analgesia: A Review of Inadvertent Soft-Tissue Injection During Implantable Drug Delivery Device Refills and Its Management. Pain Medicine 12:7, pages 1032-1040.
Crossref
Crossref
Paolo Poli & Antonella Ciaramella. (2011) Psychiatric Predisposition to Autonomic and Abnormal Perception Side-Effects of Ziconotide: A Case Series Study. Neuromodulation: Technology at the Neural Interface 14:3, pages 219-224.
Crossref
Crossref
Christoph Maier, Hans-Helmut Gockel, Kai Gruhn, Elena K. Krumova & Marc-Andreas Edel. (2011) Increased risk of suicide under intrathecal ziconotide treatment? – A warning. Pain 152:1, pages 235-237.
Crossref
Crossref
Carsten H. Nielsen, Richard H. Kimura, Nadia Withofs, Phuoc T. Tran, Zheng Miao, Jennifer R. Cochran, Zhen Cheng, Dean Felsher, Andreas Kjær, Juergen K. Willmann & Sanjiv S. Gambhir. (2010) PET Imaging of Tumor Neovascularization in a Transgenic Mouse Model with a Novel 64Cu-DOTA-Knottin Peptide. Cancer Research 70:22, pages 9022-9030.
Crossref
Crossref
Gillian Burgess & Dic Williams. (2010) The discovery and development of analgesics: new mechanisms, new modalities. Journal of Clinical Investigation 120:11, pages 3753-3759.
Crossref
Crossref
Achim Schmidtko, Jörn Lötsch, Rainer Freynhagen & Gerd Geisslinger. (2010) Ziconotide for treatment of severe chronic pain. The Lancet 375:9725, pages 1569-1577.
Crossref
Crossref